289 related articles for article (PubMed ID: 34310892)
1. Recombinant
Li P; Wang X; Sun X; Cimino J; Guan Z; Sun W
Infect Immun; 2021 Oct; 89(11):e0039621. PubMed ID: 34310892
[TBL] [Abstract][Full Text] [Related]
2. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
Li P; Wang X; Sun X; Guan Z; Sun W
mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.
Zhao K; Deng X; He C; Yue B; Wu M
Infect Immun; 2013 Dec; 81(12):4509-18. PubMed ID: 24082079
[TBL] [Abstract][Full Text] [Related]
4. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J
Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241
[TBL] [Abstract][Full Text] [Related]
5. Immunization with outer membrane proteins (OprF and OprI) and flagellin BÂ protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
6. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
[TBL] [Abstract][Full Text] [Related]
7. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
[TBL] [Abstract][Full Text] [Related]
8. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model.
Zare Banadkoki E; Rasooli I; Ghazanfari T; Siadat SD; Shafiee Ardestani M; Owlia P
Sci Rep; 2022 Dec; 12(1):22324. PubMed ID: 36566282
[TBL] [Abstract][Full Text] [Related]
11. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
[TBL] [Abstract][Full Text] [Related]
12. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
13. A chimaeric plant virus vaccine protects mice against a bacterial infection.
Brennan FR; Gilleland LB; Staczek J; Bendig MM; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2061-2067. PubMed ID: 10463172
[TBL] [Abstract][Full Text] [Related]
14. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
[TBL] [Abstract][Full Text] [Related]
16. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
17. A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
Knapp B; Hundt E; Lenz U; Hungerer KD; Gabelsberger J; Domdey H; Mansouri E; Li Y; von Specht BU
Vaccine; 1999 Mar; 17(13-14):1663-6. PubMed ID: 10194820
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
von Specht BU; Strigl G; Ehret W; Brendel W
Infection; 1987; 15(5):408-12. PubMed ID: 3121520
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
Moriyama K; Wiener-Kronish JP; Sawa T
Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
